Proteomic analysis of cases with pancreatic cancer who undergo preoperative chemoradiation therapy

Proteomic analysis of cases with pancreatic cancer who undergo preoperative chemoradiation therapy - Proteomic analysis of cases with pancreatic cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014698

Enrollment

Registered

2014-08-01

Start date

2014-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

Proteomic analysis of resected specimen

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Resected cases with pancreatic cancer who undergo preoperative chemoradiation therapy and are diagnosed histologically

Exclusion criteria

Exclusion criteria: The cases which are judged unsuitable by the doctors in charge

Design outcomes

Primary

Measure	Time frame
Identification of the protein expression that there is significant difference between good and poor prognostic cases	—

Countries

Japan

Contacts

Public ContactKentaro Miyake

Yokohama City University Department of Gastroenterological Surgery

miyekentarou@yahoo.co.jp045-787-2650

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026